This website uses cookies to enhance the user experience.
W

WAI GENETICS AS925 170 291

Research
Limited company
c/o Kåre Johan Teigen Dramsvegen 147B 9010 TROMSØ, Norge

WAI GENETICS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
5 years
since Jun 9, 2020
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
820,000
1 share class
Total number of shareholders
22
5 companies, 17 persons

Financials

Total operating income 2023
103,180
NOK
Annual total result 2023
3,762,126
NOK
Total equity 2023
6,000,000
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
Chairman-
Board Member-
Board Member-
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
431,250
52.59 %
Ordinary shares
194,990
23.78 %
Ordinary shares
51,190
6.24 %
Ordinary shares
42,500
5.18 %
Ordinary shares
17,900
2.18 %
Ordinary shares
17,400
2.12 %
W
WAI GENETICS AS
Ordinary shares
15,336
1.87 %
W
WAIAWI ARCTICA AS
Ordinary shares
10,940
1.33 %
O
OWNTHAT AS
Ordinary shares
9,430
1.15 %
Ordinary shares
8,000
0.98 %
T
TEIGEN INVEST OG HOLDING AS
Ordinary shares
5,673
0.69 %
W
WAI HOLDING OPERATIONS AS
Ordinary shares
4,791
0.58 %
Ordinary shares
4,560
0.56 %
Ordinary shares
2,000
0.24 %
Ordinary shares
880
0.11 %
Ordinary shares
830
0.1 %
Ordinary shares
800
0.1 %
Ordinary shares
600
0.07 %
Ordinary shares
330
0.04 %
Ordinary shares
260
0.03 %
Ordinary shares
240
0.03 %
Ordinary shares
100
< 0.01 %

Shares owned by the WAI GENETICS AS

NameShare classTotal number of sharesShare
W
WAI GENETICS AS
Ordinary shares
15,336
1.87 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202320222021
Total operating income
103,180
428,549
241,900
Annual Total Result
3,762,126
25,465
99,570
Total assets
12,556,910
5,536,790
2,825,178
Total liabilities
6,556,911
3,506,738
2,405,178
Total equity
6,000,000
2,030,052
420,000

P&L

Year202320222021
Total operating income
103,180
428,549
241,900
Total operating costs
105,747
459,795
142,330
Operating result
-2,567
-31,246
99,570
Financial income/costs
107,387
35,499
0
Profit before tax
104,820
4,253
99,570
Total tax & extraordinary income/cost
-3,657,306
-21,212
0
Annual Total Result
3,762,126
25,465
99,570

Balance overview

Year202320222021
Total fixed assets
12,381,073
5,441,333
2,727,163
Total current assets
175,837
95,457
98,015
Total assets
12,556,910
5,536,790
2,825,178
Short term debt
3,983,341
2,685,918
1,584,358
Long term debt
2,573,570
820,820
820,820
Total liabilities
6,556,911
3,506,738
2,405,178
Contributed capital
5,297,015
2,030,052
420,000
Retained earnings
702,985
0
0
Total equity
6,000,000
2,030,052
420,000
Total equity and liabilities
12,556,911
5,536,790
2,825,178

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology